BE Capital



Medical Industry


Advisory Service
Venture Capital
BE Bio Fund & Operation


Greater China
United States

BE Capital


BE Capital is a healthcare focused investment firm formed making investments into promising private and public hospital and healthcare technology ventures in the Greater China and U.S.

ABOUT BE capital


To become the industry’s No1 investment vehicle and medical platform

BE Capital is a boutique advisory and investment company, specializing in technologies, financials and healthcare industries.

Semiconductor and high tech industry is one specialty that BE Capital has accumulated for 30 years with a stellar successful track record.

Integration and international management standards

Mr. Martin Chen, based in Irving CA and Dr. Longsong Lin, based in Taipei, are two primary responsible managing partner and advisor for technology sector. They both have strong academic and industry background and rooted network in the ecosystem in Taiwan and Silicon Valley.

Mr. Martin Chen is a 33 years veteran entrepreneur and investor with a long proven track. Mr. Longsong Lin worked for first-tier multination technology groups such as Intel Innovation, Lenovo, AMD and Taya Venture Capital. He is still an important advisor to Taiwan’s government in driving its high tech policy.

Mr. Ben Chen, a senior banker with Baring Securities and Barclays Bank, has successfully completed many M&A deals in electronics, banking and medical industry in Taiwan and China. He is a deal maker! He knows how to structure a workable and financeable deal particularly for cross border transactions.

More than 100 years and 80 years respectively of combined professional experiences

BE Capital’s investment and hospital management teams have more than 100 years and 80 years respectively of combined professional experiences, including experts from Changhua Christian Hospital, MacKay Memorial Hospital, Choninn Hospital, Sunshine Insurance Group, and Hontai Insurance Group, and have partnered with premier hospitals in US, Taiwan and China.

Investment Strategy

  • - Greater China’s Healthcare Reform Opportunities
  • - Disruptive Medical Technologies & Business Models
  • - Synergies with BE’s Domestic and Foreign Hospital & Medical Network


Ben Chen

  • Partner: BE Capital
  • Former Chief Investment Officer: Sunshine Insurance Group, China
  • Former Chief Investment Officer: Hontai Group, Taiwan
  • Former Chairman: Hontai Life Insurance Corporation, Taiwan
  • MBA, Ohio State University; BA Economics, National Taiwan University

Mr. Martin Chen

  • US Partner: BE Capital
  • Board of Hisense Broadband, Trubuzz,
  • Founder & CEO, Vertex Networks, Inc
  • U.C. Santa Barbara, U.S.A.
  • National Chiao Tung University, Taiwan

Arthur Chen

  • Executive Director: BE Capital
  • Funding Partner: Spring Drive Accelerator
  • Former Sales Manager: Texas Instruments
  • EMBA, Columbia University, USA
  • Executive Education, Stanford, USA
  • Master of EE, National Taiwan University
  • Bachelor of Science, Material Sciences, National Chiao Tung University

Belle Liu

  • Executive Director, BE Capital
  • People’s Republic of China Attorney
  • CEO, Han-Ren Xin-Kang Clinic
  • Former Senior Manager, Healthcare Investment, Sunshine Insurance Group
  • Former Investment Manager, Beijing Co-Bridge Capital
  • LLB, Peking University
  • MBA, Tsinghua SEM


Longsong Lin

  • Partner: BE Capital
  • Chairman of Lenovo, Global Tech Taiwan
  • Acedemia Related: Distinguished Chair Professorship, Adjunct Professor
  • Ph.D., Purdue University; MSEE, Purdue University; EMBA, National Taiwan University

Portfolio with control

Daren Medical Group


BE Accelerator


BE Neo Bio Inv’t Fund






陳憲煒 Ben

林政逸 Peter

Office (Taipei)

Rm. 503, 5F., No.96, Sec. 2, Zhongshan N. Rd., Zhongshan Dist., Taipei City 10449, Taiwan (R.O.C.)

Office (Beijing)

Rm 2507, No. 16, Jian Guo Men Wai Da Jie, Beijing China

刘赟 Belle